Mitsuru Imamura

1.2k citations
25 papers · 876 indexed · h-index 15
Topics
Asthma and respiratory diseases (8 papers)IL-33, ST2, and ILC Pathways (5 papers)Immune Cell Function and Interaction (4 papers)

In The Last Decade

Mitsuru Imamura

24 papers receiving 868 citations

Peers

Mitsuru Imamura
Comparison fields: 5 of 91
  • Immunology 294
  • Molecular Biology 283
  • Physiology 214
  • Pulmonary and Respiratory Medicine 193
  • Surgery 110
Replace Vigdis Bjerkeli with:
Vigdis Bjerkeli Norway
Agnès Bellocq France
Tetsuya Homma Japan
Na Peng China
MB Atkins United States
Ryosuke Nishio Japan
Harald Schuett Germany
D Provvedini United States
Ingrid Stroo Netherlands
Heidi Wähämaa Sweden
Mitsuru Imamura relative to Vigdis Bjerkeli Norway Vigdis Bjerkeli's profile →
Citations per field
00.5×1.5×1.8×
Vigdis Bjerkeli · 1×
Citations per year

Countries citing papers authored by Mitsuru Imamura

Since Specialization
Citations

This map shows the geographic impact of Mitsuru Imamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuru Imamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuru Imamura more than expected).

Fields of papers citing papers by Mitsuru Imamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuru Imamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuru Imamura. The network helps show where Mitsuru Imamura may publish in the future.

Co-authorship network of co-authors of Mitsuru Imamura

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuru Imamura. A scholar is included among the top collaborators of Mitsuru Imamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuru Imamura. Mitsuru Imamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 10
3 5
4 131
5 22
6 89
7 56
8 17
9 29
10 10
11 14
12 61
13 68
14 47
15 12
16 6
17 57
18 65
19 19
20 29

About Mitsuru Imamura

Mitsuru Imamura is a scholar working on Immunology and Allergy, Immunology and Physiology, having authored 25 papers that have together received 876 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (8 papers), IL-33, ST2, and ILC Pathways (5 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Immunology (294 citations), Immunology and Allergy (75 citations) and Nephrology (61 citations). Mitsuru Imamura has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Makoto Dohi, Ryoichi Tanaka, Katsuhide Okunishi, Hiroaki Harada, Kazuyuki Nakagome, Augustine M.K. Choi, Kazuhiko Yamamoto, Kuei‐Pin Chung, Mary E. Choi and Kiichi Nakahira. Their work appears in journals such as Nature Communications, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026